Clinical Trial Update: Repeat Dose GW685698X With Magnesium Stearate, Excipient Bridging Study, In Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 repeat-dose study of GW685698X with magnesium stearate in healthy volunteers (excipient bridging study) completed; this is part of GlaxoSmithKline's ast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GW685698X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED